SusanEDormanMD
Infectious Disease • Charleston, SCAssociate Professor of Medicine, Johns Hopkins University School of Medicine
Are you Dr. Dorman?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 76 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
171 Ashley Ave
Charleston, SC 29425Phone+1 843-792-1414- Is this information wrong?
Summary
- Dr. Susan Dorman, MD is an infectious disease specialist in Charleston, South Carolina. She is currently licensed to practice medicine in South Carolina and Maryland. She is affiliated with MUSC Health University Medical Center and is an Associate Professor of Medicine at Johns Hopkins University School of Medicine.
Education & Training
National Institutes of Health Clinical CenterFellowship, Infectious Disease, 1996 - 1999
Brigham and Women's HospitalResidency, Internal Medicine, 1993 - 1996
Duke University School of MedicineClass of 1993
Certifications & Licensure
SC State Medical License 2017 - 2025
MD State Medical License 1996 - 2018
Clinical Trials
- TBTC Study 28: Moxifloxacin Versus Isoniazid for TB Treatment Start of enrollment: 2006 Feb 01
- TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment Start of enrollment: 2008 Dec 01
- Rifapentine Plus Moxifloxacin for Treatment of Pulmonary Tuberculosis Start of enrollment: 2009 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsRifapentine With and Without Moxifloxacin for Pulmonary Tuberculosis in People With Human Immunodeficiency Virus (S31/A5349).April C Pettit, Patrick P J Phillips, Ekaterina Kurbatova, Andrew Vernon, Payam Nahid, Rodney Dawson, Kelly E Dooley, Ian Sanne, Ziyaad Waja, Lerato Mohapi, Anthony T ...> ;Clinical Infectious Diseases. 2023 Feb 8
- 5 citationsTime-to-positivity of Mycobacterium avium complex in broth culture associates with culture conversion.Christina M Mingora, Bryan A Garcia, Kevin C Mange, Dayton W Yuen, Monika Ciesielska, Jakko van Ingen, Patrick A Flume, Susan E Dorman> ;BMC Infectious Diseases. 2022 Mar 12
- 22 citationsLatent Tuberculosis Infection.Maunank Shah, Susan E Dorman> ;The New England Journal of Medicine. 2021 Dec 9
- Join now to see all
Press Mentions
Shorter TB Treatment Regimen Demonstrates EfficacyMay 6th, 2021- Program to Present Ideas for Ending TB EpidemicMarch 12th, 2021
- MUSC Physician Wins $9.9 Million Contract to Run Trials for the Tuberculosis Trials ConsortiumFebruary 23rd, 2021
- Join now to see all
Grant Support
- Phase II Study Of Daily Rifapentine For Pulmonary Tuberculosis (Ind 62,611;1/2/0Food And Drug Administration2009–2011
- Extensively Drug-Resistant Tuberculosis Among GOLD Miners In South AfricaNational Institute Of Allergy And Infectious Diseases2008–2011
- Rapid Detection Of Mycobacterium TuberculosisNational Institute Of Allergy And Infectious Diseases2003–2007
- Mycobacterium Tuberculosis Cell Wall Virulence FactorsNational Institute Of Allergy And Infectious Diseases2003–2004
Hospital Affiliations
MUSC Health University Medical CenterCharleston, South Carolina
